About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Combination Therapy Shows Promising Results in Early Stage Breast Cancer

by Dr. Trupti Shirole on January 10, 2015 at 5:57 PM
Font : A-A+

 Combination Therapy Shows Promising Results in Early Stage Breast Cancer

A combination therapy of low-dose chemotherapy with paclitaxel and the targeted drug trastuzumab (Herceptin) showed promising results in women with early stage HER2-positive breast cancer, according to researchers at Dana-Farber Cancer Institute in Massachusetts. Women who received the treatment were highly unlikely to see their cancer return.

406 women whose tumors were smaller than three centimeters and had not spread to their lymph nodes were part of the phase II clinical trial. These women were treated with the combination therapy for 12 weeks, followed by 9 months of Herceptin alone.

Advertisement

Senior author of the study, Eric Winer, said, "Women with small, HER-2 positive, node-negative breast tumors have a low, but still significant, risk of recurrence of their disease. This study demonstrates that a combination of lower-intensity chemotherapy and trastuzumab, which is associated with fewer side effects than traditional chemotherapy regimens, is an appealing standard of care for this group of patients."

The researchers said, "Three years after completing the combination therapy, 98.7 percent of the participants were alive and free of invasive breast cancer."
Advertisement

However, Charles Shapiro, co-director of Dubin Breast Center, The Mount Sinai Hospital in New York, said, "Three years of follow-up is short, and time will tell if there are late recurrences."

The study appears in the New England Journal of Medicine.

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Cancer News

Exploring the Role of Neutrophils in Immunotherapy
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
How Can Mouse Avatars Help Treat Multiple Myeloma?
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Combination Therapy Shows Promising Results in Early Stage Breast Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests